Jun Yang

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor”.

Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor

eLife(2023)10.7554/elife.90993

N/A

0.754DataRank · unranked

35 citations

Waise Quarni, Shivendra V. Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin +16 more

Association ofGATA3Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa138

N/A

0DataRank · unranked

23 citations

Anthony Pak‐Yin Liu, Meenakshi Devidas, Shawn HR Lee, Xueyuan Cao, Deqing Pei +21 more

Mutational Landscape and Patterns of Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia

Blood Cancer Discovery(2020)10.1158/2643-3249.bcd-19-0041

N/A

0DataRank · unranked

10 citations

Zhaohui Gu, Stephanie M. Dobson, Željko Antić, Jeremy Chase Crawford, Xiaotu Ma +38 more

Prostaglandin receptor EP2 is a novel molecular target for high-risk neuroblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.24.963108

N/A

0DataRank · unranked

2 citations

Ying Yu, Davis T. Nguyen, Madison N. Sluter, Lexiao Li, Jun Yang +2 more

Faculty Opinions recommendation of Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2020)10.3410/f.736876409.793570258

N/A

0DataRank · unranked

0 citations

Heng Xu, Jun Yang

Faculty Opinions recommendation of The human tumor microbiome is composed of tumor type-specific intracellular bacteria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2020)10.3410/f.738032617.793577444

N/A

0DataRank · unranked

0 citations

Heng Xu, Jun Yang

MethylationToActivity: a deep-learning framework that reveals promoter activity landscapes from DNA methylomes in individual tumors

Genome biology(2021)10.1186/s13059-020-02220-y

N/A

0DataRank · unranked

12 citations

Beisi Xu, Daniel K. Putnam, Andrew Thrasher, Chunliang Li, Jun Yang +2 more

Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma

Cell Reports(2022)10.1016/j.celrep.2022.111000

N/A

0DataRank · unranked

17 citations

Ying Yu, Madison N. Sluter, Lexiao Li, Jiukuan Hao, Jie Fang +3 more

Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia

Blood Advances(2022)10.1182/bloodadvances.2021006152

N/A

0DataRank · unranked

15 citations

Maoxiang Qian, Yoshihiro Gocho, Wentao Yang, Guoqing Du, Shuhong Shen +3 more

A Novel Locus on 6p21.2 for Cancer Treatment–Induced Cardiac Dysfunction Among Childhood Cancer Survivors

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac115

N/A

0DataRank · unranked

14 citations

Matthew J. Ehrhardt, Na Qin, Zhaoming Wang, Qi Liu, Weiyu Qiu +23 more

Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent

Cancers(2022)10.3390/cancers15010208

N/A

0DataRank · unranked

2 citations

Andrew M. Davidoff, Jun Yang

Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators

Cell Genomics(2023)10.1016/j.xgen.2023.100442

N/A

0DataRank · unranked

16 citations

Robert J. Mobley, Jonathan D. Diedrich, Brennan P. Bergeron, Kashi Raj Bhattarai, Alexander C. Monovich +20 more

Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0312

N/A

0DataRank · unranked

5 citations

Carolyn M. Jablonowski, Jie Fang, Andrew M. Fleming, Hyea Jin Gil, Andrew S. Boghossian +9 more

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study

Research Square(2023)10.21203/rs.3.rs-2675436/v1

N/A

0DataRank · unranked

2 citations

Changde Cheng, Justin Williams, Timothy I. Shaw, Emília M. Pinto, Karissa Dieseldorff-Jones +29 more

Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.26.546606

N/A

0DataRank · unranked

1 citations

Waise Quarni, Shivendra V. Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin +16 more

Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway

British Journal of Cancer(2024)10.1038/s41416-024-02599-6

N/A

0DataRank · unranked

18 citations

Jun Yang

Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101468

N/A

0DataRank · unranked

12 citations

Jie Fang, Hongjian Jin, Shivendra V. Singh, Prahalathan Pichavaram, Qiong Wu +21 more

Monitoring drug metabolic pathways through extracellular vesicles in mouse plasma

PNAS Nexus(2024)10.1093/pnasnexus/pgae023

N/A

0DataRank · unranked

6 citations

Menchus Quan, Marco Hadisurya, Jianzhong Hu, Yi‐Kai Liu, Yuxin Zhuang +6 more

Author Response: Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor

(2024)10.7554/elife.90993.2.sa3

N/A

0DataRank · unranked

0 citations

Waise Quarni, Shivendra V. Singh, Haiyan Tan, Dhanushka Hewa Bostanthirige, Hongjian Jin +16 more

Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts☆

Journal of Pediatric Surgery(2024)10.1016/j.jpedsurg.2024.162122

N/A

0DataRank · unranked

0 citations

Carolyn M. Jablonowski, Prahalathan Pichavaram, Shivendra V. Singh, Mary A. Woolard, Christopher L. Morton +5 more

Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00157-3

N/A

0DataRank · unranked

8 citations

Qi Liu, Siddhant Taneja, Jennifer C. French, Matthew J. Ehrhardt, Tara M. Brinkman +15 more

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin

Blood(2025)10.1182/blood.2024028215

N/A

0DataRank · unranked

7 citations

Zhenhua Li, Kelly R. Barnett, Yizhen Li, Megan Walker, Satoshi Yoshimura +16 more

17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma

iScience(2020)10.1016/j.isci.2020.101996

N/A

0DataRank · unranked

16 citations

Ahmed Abu‐Zaid, Wenwei Lin, Jonathan Low, Alireza Abdolvahabi, Hongjian Jin +24 more

IL4i1-sourced oncometabolites promote neuroblastoma cell survival

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.07.669062

N/A

0DataRank · unranked

0 citations

Lee-Ann Van de Velde, Lisa Kainacher, Johanna Ruoff, Ana Bici, Nicolas B. Peterson +8 more